Dextromethorphan and guaifenesin use must be monitored meticulously in patients with "poor metabolizer" CYP2D6 enzyme degrees and individuals who are sedated. This mix medication features a significant median toxic dose (TD50) to median helpful dose (ED50) ratio (or therapeutic index) in these individuals. 资助维基百科 外观 创建账号 登录 个人工具 创建账号 Drug https://live-koala-bear-for-sale34332.thenerdsblog.com/35774454/a-review-of-dextromethorphan-dxm-for-sale-in-usa